CDK4 and breast carcinoma: Researchers have created a simple and universal nanoparticle platform loaded with palbociclib, which served as an effective inducer of ICD in breast cancer mice models receiving immunotherapy and avoided the adverse reactions of systemic use of CDK4/6is [52].